—
Kalos Therapeutics is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.Kalos has successfully leveraged the natural antiproliferative activity of the Atrial Natriuretic Peptide (ANP) family of peptides in our patented Kalos Motif (s) demonstrating never before seen anti cancer growth properties. Kalos has efficaciously identified the motif in this family of peptides that is responsible for controlling cell growth (the anti-cell proliferation motif, or ACM), and is developing a new class of anti-proliferative drugs based on this motif.
"Kalos has actually been blessed with having the world's biggest minds in oncology, drug development and corporate America come together to form our own all-star team of recognized international leaders", states Kalos CEO George Colberg. "We are really happy to reveal the addition of another worldwide leader to our dream team - Mr. Derek Vest, CEO & Founder of Gentech Pharmaceutical. Mr. Vest brings outstanding pharmaceutical innovating thinking and passion to our group along with providing Kalos with extraordinary access to Gentech's worldwide team of IT professionals."
"Kalos Therapeutics is the only bio-tech/pharmaceutical company worldwide that I am aware of that has the capability to alter the world of cancer treatment. Kalos Therapeutics drug is so superior in design and distribution compared with anything else on the market. The ability to provide a drug with virtually no side-effects is a dream coming to reality. To have a treatment with the ability to successfully deal with nine various kinds of cancer is amazing!", states Derek Vest.
About Gentech Pharmaceutical:
Gentech Pharmaceutical applies the science of perfecting and improving current medications and OTC formulations/chemical structures to produce "designer pharmacological alternatives" without the side effects. This unique ability allows Gentech Pharmaceutical to produce the most therapeutically advanced and safe pharmacological products currently available. Gentech shares the most basic and sacred goals of the physicians whom they provide products to: improve the health and well-being of patients with the safest and most effective products available. Derek Vest Leads Gentech Pharmaceutical as Founder and CEO.
Contact Info:
Name: Tiffany Ramsey
Email: Send Email
Website: http://www.gentech-pharmaceutical.com/
Release ID: 24812
Google
RSS